Left ventricular assist devices (LVADs) have become accepted as treatment for heart failure as a result of improvements in diagnosing and treating left ventricular failure and limited donor availability. In the Pivotal Study of the HeartMate II in the bridge to transplantation population, the incidence of right ventricular failure without the implantation of a right ventricular assist device was 14%, with an additional 6% of the participants ill enough that they required implantation of a right ventricular assist device. This complication increases mortality, cost, and length of stay. This article reviews the screening of LVAD candidates for the probability of right ventricular failure postoperatively, the evaluation of right ventricular function in LVAD candidates, and the optimal management of the right ventricle during the perioperative care of LVAD patients.
Symposium Continuous-Flow Ventricular Assist Devices: A New Physiological Paradigm| January 01 2012
Continuous-Flow Left Ventricular Assist Device and the Right Ventricle
AACN Adv Crit Care (2012) 23 (1): 86–90.
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
- Search Site
Mark Puhlman; Continuous-Flow Left Ventricular Assist Device and the Right Ventricle. AACN Adv Crit Care 1 January 2012; 23 (1): 86–90. doi: https://doi.org/10.4037/NCI.0b013e31823ef240
Download citation file: